Cubist Systematic Strategies, LLC Theravance Biopharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $47,955 - $67,616	5,834 New	5,834 $52,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $362,579 - $426,077	37,573 Added 33.0%	151,440 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $195,470 - $238,105	23,298 Added 25.72%	113,867 $1.16 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $537,533 - $660,891	-63,916 Reduced 41.37%	90,569 $821,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $588,622 - $915,792	70,663 Added 84.3%	154,485 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $428,415 - $638,004	57,738 Added 221.35%	83,822 $926,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $176,588 - $375,870	26,084 New	26,084 $193,000
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $177,116 - $225,324	-10,689 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $159,159 - $215,490	10,689 New	10,689 $190,000
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $454,807 - $691,589	-30,751 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $634,700 - $943,748	30,751 New	30,751 $645,000
Q1 2020 May 15, 2020	SELL	$17.84 - $31.21 $496,112 - $867,918	-27,809 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $448,281 - $719,975	27,809 New	27,809 $720,000
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $478,278 - $688,882	-28,969 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $243,781 - $393,019	15,627 Added 117.13%	28,969 $473,000
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $123,773 - $154,374	5,484 Added 69.79%	13,342 $302,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $176,962 - $275,580	7,858 New	7,858 $201,000

Others Institutions Holding TBPH

# of Institutions

124

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.6 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.8 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.3 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.4 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.6 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $643M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account